pyrazines has been researched along with Central Nervous System Viral Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, KW; Furuta, Y; Gowen, BB; Kumaki, Y; Scharton, D; Van Wettere, A; Vest, Z; Westover, JB | 1 |
1 other study(ies) available for pyrazines and Central Nervous System Viral Diseases
| Article | Year |
|---|---|
Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
Topics: Amides; Animals; Antiviral Agents; Cell Line; Central Nervous System Viral Diseases; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Microbial Sensitivity Tests; Pyrazines; Rift Valley Fever; Rift Valley fever virus; Viral Load | 2014 |